Relative Strength Chart Immutep ADR Nasdaq

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 31/05/2024 BST			5-day change	1st Jan Change
2.98 ^USD	+3.83%		+4.93%	+24.17%

07:20am	Immutep, Merck Partner for Efti and Keytruda Combo in Lung Cancer Trial	MT
03:26am	Immutep Raising AU$100 Million for Phase Three Trial	MT

End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	IMMUTEP ADR	Other Biotechnology & Medical Research	+3.83%	+4.93%	+24.17%	+43.96%	+53.61%	355M